Stocks making the biggest moves in the premarket: Boeing, Intellia Therapeutics, Perion Network & more

Stocks making the biggest moves in the premarket: Boeing, Intellia Therapeutics, Perion Network & more

(BA) – Boeing for its 777X long-range aircraft until mid-to-late 2023 at the earliest. That's according to a letter from a Federal Aviation Administration official to Boeing that was obtained by CNBC, saying there were numerous technical issues that needed to be resolved. Boeing shares fell 1.2% in the premarket. (NTLA) – Intellia shares surged 55.4% in the premarket after the Massachusetts-based company and partner (REGN) announced positive results in a phase 1 study of a gene-editing treatment for a disease called transthyretin amyloidosis. Regeneron shares gained 1.6%. Two other companies involved with the same gene-editing technology also rallied in premarket trading, with (CRSP) soaring 13.5% and (EDIT) jumping 17.1%. (PERI) – The advertising technology company's shares surged 9.9% in the premarket after reporting upbeat second-quarter earnings and increasing its full-year forecast. (JNJ) – Johnson & Johnson will pay $263 million in a settlement involving both the state and Nassau and Suffolk Counties. The settlement – in which J&J does not admit or deny guilt – removes the company from an opioid trial set to begin Tuesday. (TSLA) – Tesla to implement a software update related to assisted driving. The owners will not actually have to return the vehicles in